Abstract:Background and objective Immunotherapy holds promise in enhancing pathological complete response rates in breast cancer, albeit confined to a select cohort of patients. Consequently, pinpointing factors predictive of treatment responsiveness is of paramount importance. Gene expression and regulation, inherently operating within intricate networks, constitute fundamental molecular machinery for cellular processes and often serve as robust biomarkers. Nevertheless, contemporary feature selection approaches grapple with two key challenges: opacity in modeling and scarcity in accounting for gene-gene interactions Methods To address these limitations, we devise a novel feature selection methodology grounded in cooperative game theory, harmoniously integrating with sophisticated machine learning models. This approach identifies interconnected gene regulatory network biomarker modules with priori genetic linkage architecture. Specifically, we leverage Shapley values on network to quantify feature importance, while strategically constraining their integration based on network expansion principles and nodal adjacency, thereby fostering enhanced interpretability in feature selection. We apply our methods to a publicly available single-cell RNA sequencing dataset of breast cancer immunotherapy responses, using the identified feature gene set as biomarkers. Functional enrichment analysis with independent validations further illustrates their effective predictive performance Results We demonstrate the sophistication and excellence of the proposed method in data with network structure. It unveiled a cohesive biomarker module encompassing 27 genes for immunotherapy response. Notably, this module proves adept at precisely predicting anti-PD1 therapeutic outcomes in breast cancer patients with classification accuracy of 0.905 and AUC value of 0.971, underscoring its unique capacity to illuminate gene functionalities Conclusion The proposed method is effective for identifying network module biomarkers, and the detected anti-PD1 response biomarkers can enrich our understanding of the underlying physiological mechanisms of immunotherapy, which have a promising application for realizing precision medicine.

A Network-Based Framework to Discover Treatment-Response-Predicting Biomarkers for Complex Diseases

Network-based machine learning approach to predict immunotherapy response in cancer patients

Accelerating Complex Disease Treatment through Network Medicine and GenAI: A Case Study on Drug Repurposing for Breast Cancer

Network as a Biomarker: A Novel Network-Based Sparse Bayesian Machine for Pathway-Driven Drug Response Prediction

Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises

Identifying network biomarkers based on protein-protein interactions and expression data

A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer

BioXNet: a biologically inspired neural network for deciphering anti-cancer drug response in precision medicine

Target repositioning using multi-layer networks and machine learning: The case of prostate cancer

A network-based approach for isolating the chronic inflammation gene signatures underlying complex diseases towards finding new treatment opportunities

Discovering Explainable Biomarkers for Breast Cancer Anti-PD1 Response via Network Shapley Value Analysis

Pathway Mapping And Development Of Disease-Specific Biomarkers: Protein-Based Network Biomarkers

Atbionet– an Integrated Network Analysis Tool for Genomics and Biomarker Discovery

Integrating Prior Knowledge Into Prognostic Biomarker Discovery based on Network Structure

A biological network-based regularized artificial neural network model for robust phenotype prediction from gene expression data

AI–Driven Predictive Biomarker Discovery with Contrastive Learning to Improve Clinical Trial Outcomes

A Predictive Network-Based Immune Checkpoint Blockade Immunotherapeutic Signature Optimizing Patient Selection and Treatment Strategies

Identification of Biomarkers and Trajectories of Prostate Cancer Progression: A Bioinformatics Fusion of Weighted Correlation Network Analysis and Machine Learning

Predicting drug-disease associations by network embedding and biomedical data integration.

Pathway Mapping and Development of Disease‐specific Biomarkers: Protein‐based Network Biomarkers

Unveiling the Gut Microbiome Network Fingerprint: A Deep Learning Approach to Predict Immunotherapy Response in Melanoma Patients.